Mark your calendar for 2016

13th Annual High-Content Analysis
February 11-12, 2016 * Hilton San Diego Resort & Spa* San Diego, CA

HCA 2015 at a Glance 

Cambridge Healthtech Institute's Twelfth Annual High-Content Analysis 2015 (HCA) and Inaugural Phenotypic Screening conferences were held January 26-27, 2015 at the Hilton San Diego Resort & Spa, in San Diego, California.

More than 250 people across Pharma, Biotechnology and Academia came together in San Diego to discuss applications and technologies in the field of High-Content Analysis (HCA) and Phenotypic Screening. The events featured Dinner short courses on the Introduction to High-Content Phenotypic Screening and the Introduction to High-Content Data Analysis. HCA continues to deliver the answers as well as the attendance. This year featured participants from 16 different countries, representing 126 different organizations with more than 25% of the attendance from pharmaceutical companies. The event also featured a good networking blend of scientists (60%) and executives (25%). More than 35% of the participants were decision makers.

We hope you make plans to join us in 2016 at the Hilton San Diego Resort & Spa, San Diego, CA.

2015 Program Coverage:

  • High-Content and Phenotypic Screening in Predictive Toxicology
  • HCA Assay Development for Drug Discovery
  • Increasing Throughput in High-Content Screening
  • Data Analysis for High-Content and Phenotypic Screening
  • Phenotypic Screening Assay Development
  • Technology Integration in Phenotypic Screening
  • High-Content and Phenotypic Screening of 3D Cellular Models

Featured Speakers:

  • Anne E. Carpenter, Director, Imaging Platform, Broad Institute
  • Marc Ferrer, Team Leader, Preclinical Innovation, NCATS, NIH
  • Michael Jackson, Senior VP, Drug Discovery and Development, Sanford-Burnham Medical Research Institute
  • Stefan Kustermann, Lab Head, F. Hoffmann-La Roche
  • D. Lansing Taylor, Director, Drug Discovery Institute, University of Pittsburgh
  • Alan Waggoner, Director, Molecular Biosensor and Imaging Center, Carnegie Mellon University
  • Armin Wolf, Director, Preclinical Safety, Novartis Institutes for BioMedical Research
  • Stephen T.C. Wong, Chair, Systems Medicine and Bioengineering, Weill Cornell Medical College

Key Contacts

For content and speaker suggestions:

Julia Boguslavsky
Executive Director,
Conferences
E: juliab@healthtech.com

For partnering and sponsorship information:

Katelin Fitzgerald
Manager, Business Development
T: 781-972-5458
E: kfitzgerald@healthtech.com


For media and association partnerships:

Rich Handy
Senior Director, Marketing
Cambridge Healthtech Institute (CHI)
T: (+1) 781-972-5456
E: rhandy@healthtech.com



We are pleased to announce CHI’s Twelfth Annual High-Content Analysis meeting, the premier event showcasing the latest advancements in HCA applications and technologies. Over the years we have observed the technology mature and its adoption spread into many areas of compound screening/evaluation and functional analysis. The Twelfth Annual High-Content Analysis 2015 meeting will focus on the next steps of technology development, including new assays and probes, more advanced image analysis and data management, high-content screening of 3D models and ultra high-resolution imaging. This year, we will also co-locate CHI’s Inaugural Phenotypic Screening meeting, offering two tracks to choose from, expanded exhibit hall and an offering of user group meetings and dinner courses. The Phenotypic Screening meeting will address the advantages of phenotypic screening vs. target-based screening, and focus on assay development, selection of physiologically-relevant models and subsequent target identification, as well as case studies of phenotypic screens from leading pharma.

Programs


Phenotypic Screening 

High-Content Analysis 

Coverage Includes:

  • High-Content and Phenotypic Screening
    in Predictive Toxicology
  • HCA Assay Development for Drug Discovery
  • Increasing Throughput in High-Content Screening
  • Data Analysis for High-Content and
    Phenotypic Screening
  • Phenotypic Screening Assay Development
  • Technology Integration in Phenotypic Screening
  • High-Content and Phenotypic Screening
    of 3D Cellular Models
  • Screening in Complex
    Physiologically-Relevant Models

 

Dinner Courses:

 

FEATURED SPEAKERS:

Anne CarpenterAnne E. Carpenter

Director, Imaging Platform

Broad Institute

 

MarcFerrerMarc Ferrer

Team Leader, Preclinical Innovation

NCATS, NIH

 

MichaelJacksonMichael Jackson

Senior VP, Drug Discovery and Development

Sanford-Burnham Medical Research Institute

 

StefanKlustermannStefan Kustermann

Lab Head

F. Hoffmann-La Roche

 

Lansing TaylorD. Lansing Taylor

Director, Drug Discovery Institute

University of Pittsburgh

 

Alan WaggonerAlan Waggoner

Director, Molecular Biosensor and Imaging Center

Carnegie Mellon University

 

ArminWolfArmin Wolf

Director, Preclinical Safety

Novartis Institutes for BioMedical Research

 

StephanWongStephen T.C. Wong

Chair, Systems Medicine and Bioengineering

Weill Cornell Medical College

 
 


Katelin FitzgeraldFor exhibit & sponsorship information, please contact:
Katelin Fitzgerald
Manager, Business Development
Phone: 781-972-5458
Email: kfitzgerald@healthtech.com 
 

Julia BoguslavskyFor more details on the conference, please contact:
Julia Boguslavsky
Executive Director, Conferences
Email: juliab@healthtech.com 


Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag 


Download 2015 Brochure2015_HCA_Final 

Exclusive Executive Sponsor

Thermo Scientific large logo
 

View All Sponsors 

View Media Partners